Due to extensive overlap in the points of potential therapeutic intervention for tau and ⍺Syn (Fig. 2), and to avoid unnecessary repetition, this section will focus on the scientific premise for targeting ⍺Syn in AD, and briefly review current efforts and new approaches. Here, MAPT is linked to Alzheimer disease.